Teoxane S A Les Charmillesrue De Lyon 105geneva 1203 Pma Numberp170002 Supplement Numbers021 Date Received03 17 2022 Decision Date06 14 2022 Product Code Lmh Advisory Committee General Plastic Surgery Supplement Typereal Time Process Supplement Reason Change Design Components Specifications Material Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Teoxane S A Les Charmillesrue De Lyon 105geneva 1203 Pma Numberp170002 Supplement Numbers021 Date Received03 17 2022 Decision Date06 14 2022 Product Code Lmh Advisory Committee General Plastic Surgery Supplement Typereal Time Process Supplement Reason Change Design Components Specifications Material Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P170002S021 TEOXANE S.A.les Charmillesrue De Lyon 105geneva 1203 PMA NumberP170002 Supplement NumberS021 Date Received03/17/2022 Decision Date06/14/2022 Product Code LMH  Advisory Committee General & Plastic Surgery Supplement Typereal-time Process Supplement Reason Change Design/components/specifications/material Expedited Review Granted? No	RHA Redensity, RHA 2, RHA 3, and RHA 4 dermal fillers	2022-06-14